Ngā hua rapu - Navtej Buttar
- E whakaatu ana i te 1 - 20 hua o te 32
- Haere ki te Whārangi Whai Ake
-
1
The “Aspirin” of the New Millennium: Cyclooxygenase-2 Inhibitors mā Navtej Buttar, Kenneth K. Wang
I whakaputaina 2000Revisão -
2
-
3
-
4
-
5
The Effect of Selective Cyclooxygenase-2 Inhibition in Barrett's Esophagus Epithelium: An In Vitro Study mā Navtej Buttar, Kenneth K. Wang, Marlys Anderson, Ross Dierkhising, Rodney J. Pacifico, Krishnawatie K. Krishnadath, Lori S. Lutzke
I whakaputaina 2002Artigo -
6
A pSMAD/CDX2 Complex Is Essential for the Intestinalization of Epithelial Metaplasia mā Luigi Mari, Francesca Milano, Kaushal Parikh, Daniëlle Straub, Vincent Everts, Kees Hoeben, Paul Fockens, Navtej Buttar, Kausilia K. Krishnadath
I whakaputaina 2014Artigo -
7
-
8
Central Adiposity Is Associated With Increased Risk of Esophageal Inflammation, Metaplasia, and Adenocarcinoma: A Systematic Review and Meta-analysis mā Siddharth Singh, Anamay N. Sharma, M. Hassan Murad, Navtej Buttar, Hashem B. El‐Serag, David A. Katzka, Prasad G. Iyer
I whakaputaina 2013Revisão -
9
Significance of Neoplastic Involvement of Margins Obtained by Endoscopic Mucosal Resection in Barrett's Esophagus mā Ganapathy A. Prasad, Navtej Buttar, Louis M. Wongkeesong, Jason S. Lewis, Schuyler O. Sanderson, Lori S. Lutzke, Lynn S. Borkenhagen, Kenneth K Wang
I whakaputaina 2007Artigo -
10
Distribution of Body Fat and Its Influence on Esophageal Inflammation and Dysplasia in Patients With Barrett's Esophagus mā E. Marlo Nelsen, Yujiro Kirihara, Naoki Takahashi, Qian Shi, Jason S. Lewis, Vikneswaran Namasivayam, Navtej Buttar, Kelly T. Dunagan, Ganapathy A. Prasad
I whakaputaina 2012Artigo -
11
-
12
Long-Term Survival Following Endoscopic and Surgical Treatment of High-Grade Dysplasia in Barrett’s Esophagus mā Ganapathy A. Prasad, Kenneth K. Wang, Navtej Buttar, Louis–Michel Wongkeesong, Kausilia K. Krishnadath, Francis C. Nichols, Lori S. Lutzke, Lynn S. Borkenhagen
I whakaputaina 2007Artigo -
13
Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus mā Navtej Buttar, Kenneth K. Wang, Olga Leontovich, Jay Y. Westcott, Rodney J. Pacifico, Marlys Anderson, Krishnawatie K. Krishnadath, Lori S. Lutzke, Lawrence J. Burgart
I whakaputaina 2002Artigo -
14
Endoscopic and Surgical Treatment of Mucosal (T1a) Esophageal Adenocarcinoma in Barrett's Esophagus mā Ganapathy A. Prasad, Tsung Teh Wu, Dennis A. Wigle, Navtej Buttar, Louis–Michel Wongkeesong, Kelly T. Dunagan, Lori S. Lutzke, Lynn S. Borkenhagen, Kenneth K. Wang
I whakaputaina 2009Artigo -
15
Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma mā Navtej Buttar, Kenneth K. Wang, Thomas J. Sebo, Darren M. Riehle, Krishnawatie K. Krishnadath, Lori S. Lutzke, Marlys Anderson, Tanya M. Petterson, Lawrence J. Burgart
I whakaputaina 2001Carta -
16
Effects of Topical Steroids on Tight Junction Proteins and Spongiosis in Esophageal Epithelia of Patients With Eosinophilic Esophagitis mā David A. Katzka, Ravikanth Tadi, Thomas C. Smyrk, Eesha Katarya, Anamay N. Sharma, D. M. Geno, Michael Camilleri, Prasad G. Iyer, Jeffrey A. Alexander, Navtej Buttar
I whakaputaina 2014Artigo -
17
Gastrointestinal defect closure using a novel through-the-scope helix tack and suture device compared to endoscopic clips in a survival porcine model (with video) mā A. Hernández, Neil B. Marya, Tarek Sawas, Elizabeth Rajan, Naomi M. Gades, Louis M. Wong Kee Song, Barham K. Abu Dayyeh, Navtej Buttar, Andrew C. Storm
I whakaputaina 2021Artigo -
18
Sequence-specific Recruitment of Heterochromatin Protein 1 via Interaction with Krüppel-like Factor 11, a Human Transcription Factor Involved in Tumor Suppression and Metabolic Dis... mā Gwen Lomberk, Angela Mathison, Adrienne Grzenda, Seungmae Seo, Cathrine J. DeMars, Sumera I. Ilyas, Juliana Bonilla‐Velez, Ézéquiel Calvo, Martín E. Fernández-Zapico, Juan Iovanna, Navtej Buttar, Raúl Urrutia
I whakaputaina 2012Artigo -
19
A functional family-wide screening of SP/KLF proteins identifies a subset of suppressors of <i>KRAS</i>-mediated cell growth mā Martín E. Fernández-Zapico, Gwen Lomberk, Shoichiro Tsuji, Cathrine J. DeMars, Michael R. Bardsley, Yi–Hui Lin, Luciana L. Almada, Jing-Jing Han, Debabrata Mukhopadhyay, Tamás Ördög, Navtej Buttar, Raúl Urrutia
I whakaputaina 2011Artigo -
20
Utility of Biomarkers in Prediction of Response to Ablative Therapy in Barrett's Esophagus mā Ganapathy A. Prasad, Kenneth K. Wang, Kevin C. Halling, Navtej Buttar, Louis–Michel Wongkeesong, Alan R. Zinsmeister, Shannon M. Brankley, Emily G. Barr Fritcher, Wytske Westra, Kausilia K. Krishnadath, Lori S. Lutzke, Lynn S. Borkenhagen
I whakaputaina 2008Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Cancer
Adenocarcinoma
Biology
Esophagus
Gastroenterology
Pathology
Barrett's esophagus
Surgery
Dysplasia
Esophageal cancer
Cancer research
Chemistry
Confidence interval
Genetics
Cell biology
Gene
Endoscopy
Biochemistry
Carcinoma
Disease
Endoscopic mucosal resection
Esophagectomy
Proportional hazards model
Transcription factor
Alternative medicine
Cyclooxygenase
Enzyme
Epithelium